FRONTEO launches sales of "Coroban Care", a fall prediction AI system for long-term care facilities

2022.07.20 Press release

--To the press -

FRONTEO launches sales of "Coroban Care", a fall prediction AI system for long-term care facilities

FRONTEO Inc.
Masahiro Morimoto, President and CEO
2-12-23 Konan, Minato-ku, Tokyo
(Code number: 2158 TSE Growth)

 FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereafter FRONTEO) is pleased to announce the launch of the fall prediction AI system "Coroban Care" for long-term care facilities.

 

 FRONTEO has developed and launched "Coroban", a fall prediction AI system for medical institutions that predicts the risk of falls of inpatients from nursing records recorded in electronic medical records and displays alerts, and has been selling it since 2019. increase.The system was patented in January 2020 (patent registration number: Patent No. 1), and in March of the same year, it was certified as a recommended product by the Japan Fall Prevention Society.Furthermore, in February 6652986, the development of new functions made it possible to analyze user's fall predictions based on long-term care records at long-term care facilities.As a new product for long-term care facilities, we will start full-scale development in long-term care facilities under the brand Coroban Care.

 

 Falling / falling of elderly people not only leads to the need for long-term care / bedtime and the progression of dementia, but also has the risk of death. Equally important, various measures have been taken.On the other hand, it is more difficult than medical institutions to prevent falls in long-term care facilities, which are also a place of living, and it is difficult to deal with them in the field, which is one of the important issues in long-term care. increase.

 

 FRONTEO believes that Coroban Care will help solve this problem. FRONTEO will continue to contribute to improving the QOL of people in a super-aging society by providing solutions for solving problems in medical and long-term care settings through research and development of AI systems.

 


■ About Coroban
 URL:https://lifescience.fronteo.com/aidevice/coroban/
Coroban is a fall prediction AI system developed by FRONTEO in collaboration with Eisai Inc. FRONTEO's natural language analysis AI "Concept Encoder (trademark: concept encoder, reading: concept encoder)" reads electronic medical records and evaluates the risk of falling from the patient's condition and nursing records.It is possible to make predictions with the same accuracy as the conventional fall / fall risk assessment sheet without increasing the burden on medical staff.Recommended by the Japan Fall Prevention Society.Patent registration number: Patent No. 6652986
* This system is not a medical device.This system predicts the risk of falls and is not intended for the judgment of doctors and nurses.

■ About FRONTEO URL:https://www.fronteo.com/
FRONTEO uses the in-house developed AI engines "KIBIT", "Concept Encoder (trademark: conceptencoder, reading: concept encoder)", and "Looca Cross", which are specialized in natural language processing. It is a data analysis company that supports the business of companies by extracting meaningful and important information from a huge amount of text data. Since its establishment in August 2003, it has been expanding globally to Japan, the United States, South Korea, and Taiwan, focusing on legal tech businesses such as "e-discovery (electronic discovery)" and "digital forensic investigation" that support corporate international litigation. Has been deployed.Based on the AI ​​technology cultivated in this business, we will expand the business field to the life science field, business intelligence field, and economic security from 8, and by using AI to "turn text data into knowledge", We contribute to solving various corporate issues such as drug discovery support, dementia diagnosis support, financial, personnel, and sales support. Listed on TSE Mothers (currently TSE Growth) on June 2014, 2007. Obtained a manufacturing and sales license for first-class medical care in January 6 (permit number: 26B2021X1), and notified the managed medical device sales business in September of the same year (notification number: 13 Minato Misei Equipment No. 1).The capital is 10350 thousand yen (as of March 9, 3).

* * FRONTEO, KIBIT, conceptencoder, and Looca Cross are registered trademarks of FRONTEO in Japan.
* Coroban is a registered trademark of Eisai Co., Ltd. and FRONTEO.
* For inquiries regarding Coroban Care, please contact FRONTEO below.

 

<Contact for inquiries from the press>

Public Relations Officer, FRONTEO Inc.

Email: pr_contact@fronteo.com

 

<Contact for inquiries regarding the life science AI business>

FRONTEO Inc. Life Science AI Business Headquarters

https://lifescience.fronteo.com/contact

ja 日本語
Machine Translation by Google. : close x